WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
5 hedge funds and large institutions have $198K invested in Windtree Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$130K | |
| 2 | +$39.5K | |
| 3 | +$13.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.61K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.5K |
Top Sellers
| 1 | -$54K | |
| 2 | -$39K | |
| 3 | -$27.3K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$21.1K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$1.25K |